Hostname: page-component-586b7cd67f-vdxz6 Total loading time: 0 Render date: 2024-11-25T19:34:23.976Z Has data issue: false hasContentIssue false
  • English
  • Français

Vancomycin-Resistant Enterococci in Long-Term Care Facilities

Published online by Cambridge University Press:  02 January 2015

Shmuel Benenson ,
Matan J. Cohen ,
Colin Block ,
Sagit Stern ,
Yuval Weiss ,
Allon E. Moses  and
JIRMI Group
Shmuel Benenson*
Affiliation:
Department of Clinical Microbiology and Infectious Diseases, Jerusalem, Israel
Matan J. Cohen
Affiliation:
Center for Quality and Safety, Jerusalem, Israel
Colin Block
Affiliation:
Department of Clinical Microbiology and Infectious Diseases, Jerusalem, Israel
Sagit Stern
Affiliation:
Hadassah-Hebrew University, Jerusalem, Israel
Yuval Weiss
Affiliation:
Hadassah-Hebrew University Medical Center, Jerusalem, Israel
Allon E. Moses
Affiliation:
Department of Clinical Microbiology and Infectious Diseases, Jerusalem, Israel
*
Department of Clinical Microbiology and Infectious Diseases, Hadassah-Hebrew University Medical Center, POB 12000, Jerusalem 91120, Israel( [email protected])
Get access Rights & Permissions [Opens in a new window]

Abstract

Knowledge of the prevalence rates and associated risk markers of vancomycin-resistant enterococci (VRE) colonization among long-term care facility (LTCF) residents could be used to improve screening policies among newly admitted hospital inpatients. In a cross-sectional survey among 1,215 residents of LTCFs in Jerusalem, the VRE carriage rate was 9.6%. Previous hospitalization and antibiotic treatment were associated with elevated VRE colonization rate. In contrast, moderate and severe levels of dependency and prolonged stay, in an LTCF were associated with a decrease in the VRE colonization rate.

Type
Concise Communications
Information
Infection Control & Hospital Epidemiology , Volume 30 , Issue 8 , August 2009 , pp. 786 - 789
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2009

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Elizaga, ML, Weinstein, RA, Hayden, MK. Patients in long-term care facilities: a reservoir for vancomycin-resistant enterococci. Clin Infect Dis 2002;34:441–446.Google Scholar
2.Mahoney, FI, Barthel, DW. Functional evaluation: the Barthel index. Md State Med J 1965;14:61–65.Google ScholarPubMed
3.Isenberg, HD, ed. Clinical microbiology procedures handbook. 2nd ed. Washington, DC: ASM Press; 2004.Google Scholar
4.Dan, M, Poch, F, Leibson, L, Smetana, S, Priel, I. Rectal colonization with vancomycin-resistant enterococci among high-risk patients in an Israeli hospital. J Hosp Infect 1999;43:231–238.Google Scholar
5.Cohen, MJ, Anshelevich, O, Raveh, D, Broide, E, Rudensky, B, Yinnon, AM. Acquisition of multidrug-resistant organisms among hospital patients hospitalized in beds adjacent to critically ill patients. Infect Control Hosp Epidemiol 2006;27:675–681.Google Scholar
6.Foster, KR, Grundmann, H. Do we need to put society first? the potential for tragedy in antimicrobial resistance. PLoS Med 2006;3:e29.CrossRefGoogle ScholarPubMed
7.Harbarth, S, Cosgrove, S, Carmeli, Y. Effects of antibiotics on nosocomial epidemiology of vancomycin-resistant enterococci. Antimicrob Agents Chemother 2002;46:1619–1628.Google Scholar
8.Brennen, C, Wagener, MM, Müder, RR. Vancomycin-resistant Enterococcus faecium in a long-term care facility. J Am Geriatr Soc 1998;46:157–160.Google Scholar
9.Silverblatt, FJ, Tibert, C, Mikolich, D, et al.Preventing the spread of vancomycin-resistant enterococci in a long-term care facility. J Am Geriatr Soc 2000;48:1211–1215.Google Scholar
10.Mascini, EM, Bonten, MJ. Vancomycin-resistant enterococci: consequences for therapy and infection control. Clin Microbiol Infect 2005; 11(Suppl 4): 43–56.CrossRefGoogle ScholarPubMed